Goralatide TFA
Goralatide TFA is a cell cycle inhibitor that selectively sensitizes human hematopoietic progenitor cells to hyperthermic purging. This property makes it a candidate for ex vivo bone marrow purging in leukemia research, as studied in preclinical models.
Product Specifications
Field of Research
Immunology & Inflammation
Molecular Weight
601.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog